Elevated PRL levels have been documented in a range of 13%–59% of patients diagnosed with systemic sclerosis, suggesting a potential hormonal involvement or endocrine dysregulation in this complex autoimmune connective tissue disorder [96]. Here, PRL is linked to systemic sclerosis.